The
global pain management therapeutics market was valued at USD 40.93
billion and is expected to decline at a CAGR of (5.5%) from 2012 to
2018, to reach an estimated value of USD 29.47 billion in 2018.
Browse
the full report at Pain Management Therapeutics Market
http://www.transparencymarketresearch.com/pain-management-therapeutics.html
The
global pain management therapeutics market is expected to experience
a decline in revenues at a CAGR of (5.5%) during the forecast period,
mainly due to patent expirations of the leading branded drugs.
Although the global incidence rates of cancer, diabetes and other
debilitating diseases that cause various chronic pain conditions is
on a rise, the decline in market revenue is inevitable due to generic
incursion for the top pain management drugs. Moreover, lack of a
strong pipeline of novel or combination drugs that could help restore
the positive growth of the overall market is also expected to
contribute to the overall decline in the global pain management
therapeutics market.
Administration
of analgesics is the first line of treatment for the management of
acute as well as chronic pain conditions. Some of the factors driving
the growth of this market include the favorable regulatory and
healthcare reforms such as the U.S. Patient Protection and Affordable
Care Act of 2010. Also, the economic and effective nature of
treatment with therapeutics compared to other modes, such as
neurostimulation devices and acupuncture, will continue to fuel the
uptake of drugs in pain management.
Request
for customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1059
The
market for non-steroidal anti-inflammatory drugs (NSAIDs) accounted
for the largest share by revenue in 2011, of the total pain
management therapeutics market by therapeutic class. This class
comprises of some of the oldest known painkillers such as diclofenac,
ibuprofen and Aspirin (acetylsalicylic acid) which are now commonly
available as over-the-counter (OTC) medications, globally. However,
the patent expiry of Celebrex (celecoxib) in 2013 is expected to
negatively impact the market with a decline in revenues post patent
expiry. The class of other non-narcotic analgesics consists of
acetaminophen, sold as OTC drugs in the names of Tylenol, Panadol and
Excedrin, and is expected to record the highest CAGR of 3.1% during
the forecast period. Increase in the uptake of OTC drugs across the
globe to overcome common pain conditions such as headache and body
ache, will be responsible for this growth. The loss of patent
exclusivity of other key brands such as Cymbalta (duloxetine),
OxyContin (oxycodone) and Lidoderm (lidocaine) scheduled in the year
2013 will have a profound impact on the growth of the overall market.
North
America was the largest regional market by revenue in 2011, due to
the presence of one or more branded drugs belonging to each
therapeutic class. However, the region is expected to record the
lowest CAGR due to the looming patent expiries of these brands.
The
market for generic formulations accounted for a larger share of the
overall pain management therapeutics market in 2011, as against
branded formulations. The market for branded pharmaceuticals was
highly fragmented in 2011, with Pfizer, Inc., Purdue Pharma LP and
Eli Lilly & Co. contributing to over 80% of the total market
revenue. Other important players in this market include Endo Health
Solutions, AstraZeneca PLC, Johnson & Johnson, and Merck &
Co., Inc.
Browse
all Press Releases:
http://www.transparencymarketresearch.com/press-releases.htm
Pain
Management Therapeutics Market, by Therapeutic Class
Anticonvulsants
Antidepressants
Anesthetics
NSAIDs
Opioids
Other
Non-Narcotic Analgesics (Acetaminophen)
Anti-Migraine
Agents
Browse
all Article : http://www.transparencymarketresearch.com/articles.htm
Pain
Management Therapeutics Market, by Indication
Neuropathic
Pain
Fibromyalgia
Arthritic
Pain, by Type
Osteoarthritis
Rheumatoid
Arthritis
Chronic
Back Pain
Migraine
Post-operative
Pain
Cancer
Pain
Pain
Management Therapeutics Market, by Geography
North
America
Europe
Asia-Pacific
Rest
of the World (RoW)
Browse
all Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About
Us
TransparencyMarket
Researchis a global market intelligence company, providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. We are privileged with
highly experienced team of Analysts, Researchers, and Consultants,
who use proprietary data sources and various tools and techniques to
gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Sheela
AK
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
No comments:
Post a Comment